16mg retatrutide Promises Big Weight Loss, but Safety Remains a Question Retatrutide Phase 3: 60% Achieved

Retatrutide: Phase 2 data showed A1c reductions of 1.5-2.0%, with the glucagon component adding complexity to blood sugar management

Modulation of postprandial GLP-1 secretion and glycemic responses by a food-grade GLP-1 formula in human subjects

In humans, a Mediterranean diet rich in olive oil led to higher post-meal GLP-1 levels, improved insulin sensitivity, and lower fasting and post-meal blood glucose levels compared to a diet high in saturated fats

GLP-1s mimic these actions and, as theyre resistant to the enzyme DPP4, have a longer-lasting impact on our appetite

For women with PCOS considering future treatment, this pattern is similar to what has been observed with existing weight loss treatments in this class